Chapter 40
Liver Tumors in Asia
Norihiro Kokudo MD, PhD,
Sumihito Tamura MD, PhD,
Masatoshi Makuuchi MD, PhD,
Norihiro Kokudo MD, PhD
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, University of Tokyo, Tokyo, Japan
Search for more papers by this authorSumihito Tamura MD, PhD
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, University of Tokyo, Tokyo, Japan
Search for more papers by this authorMasatoshi Makuuchi MD, PhD
Department of Hepato-Biliary-Pancreatic, Surgery, President Japanese Red Cross Medical Center, Tokyo, Japan
Search for more papers by this authorNorihiro Kokudo MD, PhD,
Sumihito Tamura MD, PhD,
Masatoshi Makuuchi MD, PhD,
Norihiro Kokudo MD, PhD
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, University of Tokyo, Tokyo, Japan
Search for more papers by this authorSumihito Tamura MD, PhD
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, University of Tokyo, Tokyo, Japan
Search for more papers by this authorMasatoshi Makuuchi MD, PhD
Department of Hepato-Biliary-Pancreatic, Surgery, President Japanese Red Cross Medical Center, Tokyo, Japan
Search for more papers by this authorBook Editor(s):Pierre-Alain Clavien MD, Phd, FACS, FRCS,
Stefan Breitenstein MD,
Pierre-Alain Clavien MD, Phd, FACS, FRCS
Professor Chairman
Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland
Search for more papers by this authorStefan Breitenstein MD
Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland
Search for more papers by this authorSummary
This chapter contains sections titled:
-
Historical background
-
Hepatocellular carcinoma
-
Cholangiocellular carcinoma
-
Secondary liver tumors
-
Other primary liver tumors
-
References
-
Self-assessment questions
-
Self-assessment answers
References
- Lortat-Jacob JL, Robert HG. Hepatectomie droite reglee. Presse Med 1952; 60: 549–51.
- Honjo I, Araki C. Total resection of the right lobe of the liverreport of a successful case. J Int Coll Surg 1955; 7: 23–8.
- Healey JE, Schroy PC. Anatomy of the biliary ducts within the human liver. Analysis of the prevailing pattern of branchings and the major variations of the biliary ducts. Arch Surg 1953; 66: 599–616.
- Ohno Y. Resection of liver cancer [in Japanese]. Tokyo Iji Shinpo Shi 1937; 3014: 8–11.
- Lin T-Y, Tsu KY, Mien C, et al. Study on lobectomy of the liver. J Formosa Med Assoc 1958; 57: 742–59.
- Lin T-Y, Chen KM, Lin T-K. Total right hepatic lobectomy for primary hepatoma. Surgery 1969; 48: 1048–60.
- Ong GB, Lee NW. Hepatic resection. Br J Surg 1966; 62: 421–30.
- Makuuchi M, Hasegawa H, Yamazaki S, et al. Newly devised intraoperative probe. Image Technol Information Display Med 1979; 11: 1167.
- Makuuchi M, Hasegawa H, Yamazaki S, et al. The use of operative ultrasound as an aid to liver resection in patients with hepatocellular carcinoma. World J Surg 1987; 11: 615–21.
- Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985; 161: 346–50.
- Hasegawa K, Kokudo N, Imamura H, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242: 252–9.
- Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107: 521–7.
- Nagasue N, Kohno H, Matsuo S, et al. Segmental (partial) liver transplantation from a living donor. Transplant Proc 1992; 24: 1958–9.
- Makuuchi M, Kawasaki S, Iwanaka T, et al. Living related liver transplantation. Surg Today 1992; 22: 297–300.
- Hashikura Y, Makuuchi M, Kawasaki S, et al. Successful living-related partial liver transplantation to an adult patient. Lancet 1994; 343: 1233–4.
- El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557 –6.
- Parkin DM, Whelan SL, Ferlay J, et al. Cancer Incidence in Five Continents, vol VII. IARC Science Publications No. 143. Lyons: IARC, 1997.
- Ogunbiyi JO. Hepatocellular carcinoma in the developing world. Semin Oncol 2001; 28: 179–87.
- Wogan GN. Aflatoxin as a human carcinogen. Hepatology 1999; 30: 573–5.
- Ikai I, Arii S, Okazaki M, et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007; 37: 676–91.
- Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671–5.
- Oka H, Kurioka N, Kim K, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680–7.
- Kew MC, Yu MC, Kedda M-A, et al. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in Southern African blacks. Gastroenterology 1997; 112: 184–7.
- Chen W, Wang LY, Lu SN, et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 1994; 24: 38–42.
- Sun Z, Lu P, Gail MH, et al. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary afl atoxin metabolite M1. Hepatology 1999; 30: 379–83.
-
Leung NW, Tam JS, Lai JY, et al. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong? Cancer 1992; 70: 40–4.
10.1002/1097-0142(19920701)70:1<40::AID-CNCR2820700107>3.0.CO;2-P PubMed Web of Science® Google Scholar
- Tangkijvanich P, Hirsch P, Theamboonlers A, et al. Association of hepatitis virus with hepatocellular carcinoma in Thailand. J Gastroenterol 1999; 34: 227–33.
- Akriviadis EA, Llovet JM, Efremidis SC, et al. Hepatocellular carcinoma. Br J Surg 1998; 85: 1319–31.
- Shresta S M, Okuda K, Uchida T, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava. J Gastroenterol Hepatol 1996; 11: 170–9.
- Chang MH, Shau WY, Chen CJ, et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 2000; 284: 3040–2.
- Kubo Y, Okuda K, Musha H, et al. Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease. Observations in 31 patients. Gastroenterology 1978; 74: 578–82.
- The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211: 277–87.
- Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729–38.
- Takayama T, Makuuchi M, Hirohashi S, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998; 28: 1241–6.
- Liaw Y-F, Tai D-R, Chu C-M, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. Gastroenterology 1986; 90: 263–7.
- Sato Y, Nakata K, Kato Y, et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993; 328: 1802–6.
- Liebman HA, Furie BC, Tong MJ, et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984; 310: 1427–31.
- Makuuchi M, Kokudo N, Arii S, et al. Development of evidencebased clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 2008; 38: 37–51.
- Yuan M-F, Cheng C-C, Lauder IJ, Lam S-K, Ooi G-CC, Lai C-L. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31: 330–5.
- Kokudo N, Bandai Y, Imanishi H, et al. Management of new hepatic nodules detected by intraoperative ultrasonography during hepatic resection for hepatocellular carcinoma. Sugery 1996; 119: 634–40.
- Zhang K, Kokudo N, Hasegawa K, et al. Detection of new tumors by intraoperative ultrasonography during repeated hepatic resections for hepatocellular carcinoma. Arch Surg 2007; 142: 1170–5.
- Sudan D, Sudan R, Schafer D, et al. Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma. Hepatology 1998; 28: 270–1.
- Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 2000; 32: 1224–9.
- Belghiti J. Systematic hepatectomy for liver cancer. J Hepatobiliary Pancreat Surg 2005; 12: 362–4.
- Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62–7.
- Minagawa M, Makuuchi M, Takayama T, et al. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001; 233: 379–84.
- Chen M-F, Hwang T-L, Jeng L-B, et al. Postoperative recurrence of hepatocellular carcinoma. Two hundred fi ve consecutive patients who underwent hepatic resection in 15 years. Arch Surg 1994; 129: 738–42.
- Fan S-T, Lo CM, Liu CL, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999; 229: 322–30.
- Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122–30.
- Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321–8.
- Yamada K, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397–401.
- Takayasu K, Arii S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131: 461–9.
- Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693–9.
- Todo S, Furukawa H; Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma. Experience in Japan. Ann Surg 2004; 240: 451–61
- Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94: 78–86.
- Ito T, Takada Y, Ueda M, et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007; 13: 1637–44.
- Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 2005; 11: 1265–72.
- Soejima Y, Taketomi A, Yoshizumi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007; 83: 893–9.
- Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394–403.
- Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis Sci 2007; 25: 310–12.
- Kokudo N, Sasaki Y, Nakayama T, et al. Dissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons and primary care physicians. Gut 2007; 56: 1020–1.
- Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer. Tokyo: Kanehara & Co Ltd, 1997: 21.
- Parkin DM, Ohshima H, Srivatanakul P, et al. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev 1993; 2: 537–44.
-
Sugihara S, Kojiro M. Pathology of cholangiocarcinoma. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer Verlag, 1987.
10.1007/978-4-431-68349-0_11 Google Scholar
- Chen M-F, Jan Y-Y, Jeng L-B, et al. Intrahepatic cholangiocarcinoma in Taiwan. J Hepatobiliary Pancreat Surg 1999; 6: 136–41.
- Inoue K, Makuuchi M, Takayama T, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000; 127: 498–505.
- Chu K-M, Fan S-T. Intrahepatic cholangiocarcinoma in Hong Kong. J Hepatobiliary Pancreat Surg 1999; 6: 149–53.
- Kim H-J, Yun S-S, Jung K-H, et al. Intrahepatic cholangiocarcinoma in Korea. J Hepatobiliary Pancreat Surg 1999; 6: 142–8.
- Uttaravichien T, Bhudhisawasdi V, Pairojkul C, et al. Intrahepatic cholangiocarcinoma in Thailand. J Hepatobiliary Pancreat Surg 1999; 6: 128–35.
- Lee CL, Ko YC. Survival and distribution pattern of childhood liver cancer in Taiwan. Eur J Cancer 1998; 34: 2064–7.
- Foster JH, Berman MM. Solid Liver Tumors. Major Problems in Clinical Surgery. Philadelphia: WB Saunders, 1977: 1 –342.
- Kokudo N. Seki M, Ohta H, et al. Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases. Ann Surg Oncol 1988; 5: 706–12.
- Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Ann Surg 2000; 231: 487–99.
- The Liver Cancer Study Group of Japan. The 14th Report of the Nationwide Survey of Primary Liver Cancer in Japan (1996-1997) [in Japanese]. Kyoto: The Liver Cancer Study Group of Japan, 2000.
